Showing results (1301-1310 of 10,440) with videos related to
Sort By:
Pageof 1,044
AIDS (London, England)|March 28, 2003
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral loadJuan A Arnaiz, Josep Mallolas, Daniel Podzamczer, et al.AIDS (London, England)|March 28, 2003
Rectal use of nonoxynol-9 among men who have sex with menGordon Mansergh, Gary Marks, Melissa Rader, et al.AIDS (London, England)|November 1, 2002
Rapid reconstitution of humoral immunity against cytomegalovirus but not HIV following highly active antiretroviral therapyJane R Deayton, Caroline A Sabin, William B Britt, et al.AIDS (London, England)|November 1, 2002
Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infectionSahra Abdulle, Lars Hagberg, Bo Svennerholm, et al.AIDS (London, England)|November 1, 2002
Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitorsUlrich A Walker, Bernhard Setzer, Nils VenhoffAIDS (London, England)|November 1, 2002
Parents' disclosure of HIV to their childrenMartha B Lee, Mary Jane Rotheram-BorusAIDS (London, England)|November 21, 2002
Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West AfricaNicolas Meda, Valériane Leroy, Ida Viho, et al.AIDS (London, England)|November 21, 2002
Estimating the effectiveness and efficiency of US HIV prevention efforts using scenario and cost-effectiveness analysisDavid R HoltgraveAIDS (London, England)|October 9, 2002
Lack of Epstein-Barr virus- and HIV-specific CD27- CD8+ T cells is associated with progression to viral disease in HIV-infectionDebbie van Baarle, Stefan Kostense, Egbert Hovenkamp, et al.AIDS (London, England)|October 9, 2002
Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemiaAna Barrios, Francisco Blanco, Teresa García-Benayas, et al.Pageof 1,044